NCT01911637View on ClinicalTrials.gov

Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy
Interventions
DRUG

VBY-036

Study drug VBY-036

DRUG

Placebo

Placebo

Trial Locations (1)

47710

Covance Evansville, Evansville

All Listed Sponsors
lead

Virobay Inc.

INDUSTRY

NCT01911637 - Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A) | Biotech Hunter | Biotech Hunter